The registrant's Chief Financial Officer (and principal financial officer), William W. Rahhal, announced his retirement from registrant and resignation from his position as Chief Financial Officer of the registrant effective December 31, 2023.
on January 1, 2024, Thomas G. Zernick will begin service as the Company’s Chief Executive Officer and he will continue to serve as a member of the Company’s Board of Directors.
the Board appointed Christine Barone as Chief Executive Officer of the Company and its subsidiaries, in addition to her position as President of the Company and its subsidiaries, effective January 1, 2024
Joth Ricci resigned from his position as Chief Executive Officer of the Company and each of its subsidiaries and all other positions he held with the Company and each of its subsidiaries, and resigned as a member of the Board, all effective December 31, 2023.
On December 22, 2023, L3Harris Technologies, Inc. ("L3Harris") entered into a Release of All Claims Agreement (the "Agreement") with Michelle L. Turner, which was approved by the Compensation Committee of L3Harris' Board of Directors.
Departed
(interim)
Ahmed Shebl
Chief Accounting Officer and Interim Chief Financial Officer
META MATERIALS INC.
Effective
2024-01-19
Filed
December 29, 2023, 6:59 PM ET
On December 23, 2023, Ahmed Shebl, the Chief Accounting Officer and Interim Chief Financial Officer of Meta Materials Inc. (also referred to herein as the “Company”, “META”, “we”, “us”, or “our”), tendered his resignation to the Company to pursue another professional opportunity.
Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) effective January 31, 2024.
As previously reported, on November 6, 2023, the Board of Directors (the “Board”) of BRC Inc. (the “Company”) appointed Chris Mondzelewski as Chief Executive Officer of the Company, effective January 1, 2024
the Board of Directors (the “Board”) of the Company appointed Mr. Grant Begley, currently Chairman of the Board, to serve as the Interim Chief Executive Officer of the Company, effective January 1, 2024
Effective December 29, 2023, Timothy L. Triplett resigned as the Company’s Chief Executive Officer for family reasons.
Departed
Elliot Maltz
Chief Financial Officer, Treasurer and Secretary
Orgenesis Inc.
Effective
2023-12-31
Successor
Victor Miller
Filed
December 29, 2023, 6:59 PM ET
On December 22, 2023, Mr. Elliot Maltz, the Chief Financial Officer, Treasurer and Secretary of Orgenesis Inc. (the "Company"), resigned from all positions he held with the Company to pursue other opportunities.
Appointed
Victor Miller
Chief Financial Officer
Orgenesis Inc.
Effective
2024-01-02
Filed
December 29, 2023, 6:59 PM ET
On December 28, 2023, the Company appointed Victor Miller as its Chief Financial Officer, effective January 2, 2024.
Appointed
(interim)
Michael Ramke
interim Chief Financial Officer
ADDVANTAGE TECHNOLOGIES GROUP INC
Effective
2024-01-04
Filed
December 29, 2023, 6:59 PM ET
In connection with Mr. Rutledge’s resignation, the Board of Directors appointed Michael Ramke as the interim Chief Financial Officer of the Company, effective January 4, 2024.
Departed
Michael Rutledge
Chief Financial Officer
ADDVANTAGE TECHNOLOGIES GROUP INC
Effective
2024-01-04
Successor
Michael Ramke
Filed
December 29, 2023, 6:59 PM ET
On December 26, 2023, Michael Rutledge, the Chief Financial Officer ADDvantage Technologies Group, Inc., an Oklahoma corporation (the “Company”), resigned from the Company, effective January 4, 2024.
Departed
Aiden Neary
Chief Financial Officer
NewStream Energy Technologies Group Inc
Effective
2023-12-22
Filed
December 28, 2023, 6:59 PM ET
On December 22, 2023, NewStream Energy Technologies Group Inc. (the “Company”) was informed by Aiden Neary, the Company’s Chief Financial Officer and Director, that he has resigned from such positions effective December 22, 2023.
On December 22, 2023, Alaunos Therapeutics, Inc. (the “Company”) entered into a Separation and Release Agreement, effective December 22, 2023, with Kevin S. Boyle, Sr. (the “Separation Agreement”), the Company’s Chief Executive Officer, in connection with Mr. Boyle’s termination.
Appointed
Xiaocheng Peng
Chief Financial Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Xiaocheng Peng, will become the permanent chief financial officer of the Company and non-independent director.
Departed
Zikang Wu
Chief Executive Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Successor
Jiande Chen
Filed
December 28, 2023, 6:59 PM ET
Zikang Wu shall resign as chief executive officer, to be effective upon the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder.
Appointed
Jiande Chen
Chief Executive Officer
Healthcare AI Acquisition Corp.
Effective
2023-12-28
Filed
December 28, 2023, 6:59 PM ET
Jiande Chen will replace Zikang Wu as Chief Executive Officer of the Company and chairman of the Board.
On December 22, 2023, the Board appointed Mr. Hopkins as Interim Chief Executive Officer and President of the Company, to serve in such capacity until a successor is duly appointed and approved by the Board.
On December 26, 2023, Xuqiang (Adam) Yang, was appointed as Chief Financial Officer (“CFO”) of SMCE Entertainment, Inc. (“SMCE”) to replace Erik Blum, the Company’s Chief Executive Officer, who was also serving as SMCE’s Interim CFO.
Nathan Bennett, the current Corporate Controller of the Company, will be appointed as Chief Accounting Officer and Interim Chief Financial Officer of the Company effective January 1, 2024.
On December 22, 2023, the Board of Directors of Clover Health Investments, Corp. (the “Company”) appointed Mr. Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024.
the Board appointed Steven Vontur, the current Controller and Principal Accounting Officer of the Company, to serve as the Company’s Interim Chief Financial Officer, effective as of January 26, 2024.
Erik Sallee, the Chief Financial Officer of the Company informed the Company of his intention to resign from his position with the Company and its subsidiaries, effective as of January 26, 2023, for family and personal reasons
Departed
Stewart F.B. Baker
Executive Vice President, Chief Financial Officer and principal accounting officer
On December 20, 2023, the Company accepted the resignation of Mr. Stewart F.B. Baker as Executive Vice President, Chief Financial Officer and principal accounting officer of Inspired Entertainment, Inc.
Effective December 20, 2023, the Board of Directors of the Company appointed Marilyn Jentzen, age 57, as the Interim Chief Financial Officer of the Company.
Appointed
William C. Erbey
Chief Executive Officer and Chairman
Altisource Asset Management Corp
Effective
2023-12-21
Filed
December 26, 2023, 6:59 PM ET
On December 21, 2023, Altisource Asset Management Corporation (the "Company") announced that William C. Erbey as the new Chief Executive Officer of the Company. In addition, the Board of Directors of the Company has appointed Mr. Erbey as its Chairman effective as of December 21, 2023.
On December 22, 2023, Life Time Group Holdings, Inc. (the “Company”) agreed with Robert Houghton, the Company’s Executive Vice President and Chief Financial Officer, that Mr. Houghton will resign from his position as Chief Financial Officer effective as of December 31, 2023 and will cease his service to the Company effective January 5, 2024.
The Company has appointed Erik Weaver, the Company’s Senior Vice President and Controller, to the additional position of interim Chief Financial Officer effective January 1, 2024.
Departed
Adam Laponis
Chief Financial Officer
Eargo, Inc.
Effective
2024-01-05
Successor
Mark Thorpe
Filed
December 22, 2023, 6:59 PM ET
On December 19, 2023, Adam Laponis notified Eargo, Inc. (“Eargo” or the “Company”) that he will step down as Chief Financial Officer and depart Eargo on January 5, 2024.
Appointed
Mark Thorpe
Chief Financial Officer
Eargo, Inc.
Effective
2024-01-05
Filed
December 22, 2023, 6:59 PM ET
On December 19, 2023, Eargo appointed Mark Thorpe as Chief Financial Officer, effective January 5, 2024, to succeed Mr. Laponis.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.